Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution.
Rev Bras Epidemiol
; 26: e230045, 2023.
Article
in En, Pt
| MEDLINE
| ID: mdl-37878833
Fulltext
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642446
- https://dx.doi.org/10.1590/1980-549720230045
- http://www.scielo.br/scielo.php?script=sci_arttext&nrm=iso&lng=pt&tlng=pt&pid=S1415-790X2023000100441
- http://www.scielosp.org/scielo.php?script=sci_arttext&nrm=iso&lng=pt&tlng=pt&pid=S1415-790X2023000100441
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
America do sul
/
Brasil
Language:
En
/
Pt
Journal:
Rev Bras Epidemiol
Journal subject:
EPIDEMIOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Brazil